Everolimus Implicated in Case of Severe Gastrointestinal Hemorrhage
Breast cancer remains the leading cause of cancer and the third leading cause of cancer related deaths among Console Mast Assembly our population with an estimated number of 246,660 new cases and 40,450 deaths in 2016.With treatment advancements, including targeted agents such as Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, surviva